English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/121142
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Antithrombin Murcia (K241E) causing antithrombin deficiency: a possible role for altered glycosylation

AuthorsMartínez-Martínez, Irene; Ordóñez, Adriana; Navarro-Fernández, José; Pérez-Lara, Ángel; Gutiérrez-Gallego, Ricardo; Giraldo, R. ; Martínez, Constantino; Llop, Esther; Vicente, Vicente; Corral, Javier
KeywordsAntithrombin
Glycosylation
Heparin
Issue Date2010
PublisherFerrata Storti Foundation
CitationHaematologica 95(8):1358-1365 (2010)
AbstractBackground Identification of mutations in the SERPINC1 gene has revealed different mechanisms responsible for antithrombin deficiency. Deletions and nonsense mutations associate with type I deficiency. Certain missense mutations cause type II deficiency by affecting the heparin binding site or the reactive center loop, while others result in type I deficiency by intracellular retention or RNA instability. Design and Methods We studied the molecular, biochemical, proteomic and glycomic characterization of a new natural mutant (K241E) that may be classified as pleiotropic. Results The mutation caused a significant decrease in the anticoagulant activity mainly due to a reduced heparin affinity and a modification of the electrostatic potential that might explain the impaired ability of the mutant protein to form complexes with the target protease in the absence of heparin. Mass spectrometry and glycomic analyses confirmed an increased molecular weight of 800 Da in the mutant protein possibly due to core-fucosylation, provoking the loss of heparin affinity. Additionally, carriers of this mutation also have a minor mutant isoform that still followed normal glycosylation, retaining similar heparin affinity to wild-type α−antithrombin, and certain anticoagulant activity, which may explain the milder thrombotic risk of patients carrying this mutation. Similar results were observed using recombinant K241E antithrombin molecules. Conclusions Our data suggest a new mechanism involved in antithrombin type II deficiency by indirectly affecting the glycosylation of a natural variant. Additional studies are required to confirm this hypothesis.
Description8 p.-8 fig.
Publisher version (URL)http://dx.doi.org/ 10.3324/haematol.2009.015487
URIhttp://hdl.handle.net/10261/121142
DOI10.3324/haematol.2009.015487
ISSN0390-6078
E-ISSN1592-8721
Appears in Collections:(CIB) Artículos
Files in This Item:
File Description SizeFormat 
Haematologica_2010.pdfArtículo principal453 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.